← back to search

Jo Carter

Cambridge University Hospitals NHS Foundation Trust · GB
Area of research
Genetics · Biotechnology
Research interest
Research interests include Medicine, Nivolumab, Tolerability, Adverse effect, and Internal medicine.
h-index
—
citations
45
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
Journal for ImmunoTherapy of Cancer 2023cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lee S. Rosen · APLA Health1 papers (2023–2023)Jordan Berlin · Vanderbilt University1 papers (2023–2023)— · 1 papers (2023–2023)Minesh Patel · Imperial College Healthcare NHS Trust1 papers (2023–2023)Hani M. Babiker · Southwestern Medical Center1 papers (2023–2023)Marwan Fakih · City Of Hope National Medical Center1 papers (2023–2023)Lola Parfitt · University of Birmingham1 papers (2023–2023)Daruka Mahadevan · University of Arizona1 papers (2023–2023)— · 1 papers (2023–2023)Mark Powell · AstraZeneca (United States)1 papers (2023–2023)— · 1 papers (2023–2023)Chris D. Cox · University of Tennessee at Knoxville1 papers (2023–2023)